Analysts Offer Insights on Healthcare Companies: CalciMedica (CALC) and GE Healthcare Technologies Inc (GEHC)
CalciMedica Analyst Ratings
Optimistic Buy Rating for CalciMedica Backed by Strong Financials and Promising Clinical Trials
Analysts Offer Insights on Healthcare Companies: CalciMedica (CALC), Acrivon Therapeutics, Inc. (ACRV) and Viking Therapeutics (VKTX)
Analysts Offer Insights on Healthcare Companies: CalciMedica (CALC), Apollomics (APLM) and Iterum Therapeutics (ITRM)
CalciMedica Analyst Ratings
CalciMedica (CALC) Gets a Buy From Oppenheimer
CalciMedica Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Imunon (IMNN) and CalciMedica (CALC)
CalciMedica Analyst Ratings
CalciMedica Analyst Ratings
CalciMedica's Auxora Braces for Phase 2 Trial With Strong Buy Rating From Analyst Joseph Pantginis
CalciMedica Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Humana (HUM) and CalciMedica (CALC)
Oppenheimer Reiterates Outperform on CalciMedica, Maintains $14 Price Target
CalciMedica Analyst Ratings
Oppenheimer Reaffirms Their Buy Rating on CalciMedica (CALC)
Oppenheimer Initiates Coverage On CalciMedica With Outperform Rating, Announces Price Target of $14
Analysts Offer Insights on Healthcare Companies: Axcella Health (AXLA) and Graybug Vision (GRAY)
Analysts Offer Insights on Healthcare Companies: Adicet Bio (ACET), Hookipa Pharma (HOOK) and Graybug Vision (GRAY)
No Data